Spire Healthcare Group Aktie
| 2,62EUR | -0,02EUR | -0,76% |
WKN DE: A117ZX / ISIN: GB00BNLPYF73
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 39,01 |
| Fidelity Invt. Funds - Special Situations Fund | 6,49 |
| Société Générale Gestion SA | 2,21 |
| Fidelity Special Values Plc | 2,14 |
| Barclays Investment Solutions Ltd. | 2,01 |
| Invesco UK Invt. Ser. - UK Growth Fund (UK) | 1,51 |
| Schroder UK Mid 250 Fund | 1,44 |
| M&G (Lux) Investment Funds 1 - European Strategic Value Fund | 1,36 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 11 498 | 11 943 | 12 318 | 12 889 | 13 236 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,09 | 0,08 | 0,09 | 0,09 | 0,10 |
Bilanz (in Mio. GBP) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 199 | 250 | 342 | 219 | 220 |
| Summe Anlagevermögen | 2 088 | 1 855 | 1 895 | 1 941 | 2 069 |
| Summe Aktiva | 2 287 | 2 105 | 2 237 | 2 160 | 2 288 |
Bilanz (in Mio. GBP) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 1 347 | 1 398 | 1 533 | 1 435 | 1 550 |
| Summe Eigenkapital | 940 | 707 | 705 | 725 | 738 |
| Summe Passiva | 2 287 | 2 105 | 2 237 | 2 160 | 2 288 |
Adresse
| 3 Dorset Rise, EC4Y 8EN London | |
| Telefon | +44 (20) 7427-9000 |
| Fax | +44 (20) 7427-9001 |
| Internet | http://www.spirehealthcare.com |
Management
|
Angus Prentice
Director-Investor Relations |
|
Antony Mannion
Director-Strategy & Investor Relations |
|
C. A. Ronnie van der Merwe
Non-Executive Director |
|
Cathy Cale
Group Director-Medical |
|
Clifford Shearman
Independent Non-Executive Director |
|
Dame Janet Husband
Independent Non-Executive Director |
|
Debra J. White
Senior Independent Director |
|
Harbant Samra
Chief Financial Officer & Executive Director |
|
Ian Michael Cheshire
Non-Executive Chairman |
|
Jenny Kay
Independent Non-Executive Director |
|
John Forrest
Chief Operating Officer |
|
Justinian Joseph Ash
Chief Executive Officer & Executive Director |
|
Lisa Grant
Chief Nurse & Group Clinical Director |
|
Mantraraj Dipak Budhdev
Secretary & General Counsel |
|
Natalie Anna Ceeney
Independent Non-Executive Director |
|
Paula Bobbett
Independent Non-Executive Director |
|
Peter James Corfield
Chief Commercial Officer |
|
Rachel King
Group Director-People |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
